Francesca Saggiani
University of Verona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Francesca Saggiani.
Diabetic Medicine | 2004
Enzo Bonora; Giovanni Targher; Gianni Formentini; Francesco Calcaterra; Simonetta Lombardi; F. Marini; Luciano Zenari; Francesca Saggiani; M. Poli; S. Perbellini; A. Raffaelli; L. Gemma; Lorenza Santi; Riccardo C. Bonadonna; Michele Muggeo
Aims To evaluate the cardiovascular risk associated with the presence of the Metabolic Syndrome in Type 2 diabetic subjects.
Diabetes Care | 1995
Beatrice Marina Zenere; Guido Arcaro; Francesca Saggiani; Luca Rossi; Michele Muggeo; Alessandro Lechi
OBJECTIVE To test endothelial function in a group of 10 normoalbuminuric and eight microalbuminuric insulin-dependent diabetes mellitus patients (ages 28 ± 3 [mean ± SE] and 28 ± 1 years, respectively), in comparison with 16 control subjects (age 35 ± 2 years, normal subjects vs. diabetic subjects P = NS), to identify prestructural abnormalities of the arterial wall. An early stage of vascular involvement seems in fact to be characterized by functional alterations of endothelial control on vascular tone and wall interaction with circulating cells. Furthermore, many recent studies suggest the importance of microalbuminuria as an early marker not only of nephropathy but also of retinopathy and macroangiopathy. RESEARCH DESIGN AND METHODS Endothelium-mediated flow-dependent vasodilation and endothelium-independent vasodilation (induced by glyceryl trinitrate administration) were evaluated in the right common femoral artery by echo-Doppler ultrasound. Arterial wall distensibility was evaluated at the common femoral artery by an echo-tracking system. RESULTS In spite of a comparable increase in flow velocity, endothelium-mediated vasodilation was significantly reduced in diabetic subjects, particularly in microalbuminuric patients. Endothelium-independent vasodilation was also significantly impaired in diabetic subjects, particularly in microalbuminuric subjects; whereas arterial wall distensibility, an index of the viscoelastic properties of the wall, was similar in the three groups. CONCLUSIONS These results confirm a reduced vasodilatory capacity in diabetes mellitus, with a more marked alteration in microalbuminuric diabetic subjects. This reliable, noninvasive evaluation of arterial function is particularly useful for early diagnosis of vascular involvement.
Metabolism-clinical and Experimental | 1996
Francesca Saggiani; Stefano Pilati; Giovanni Targher; Paola Branzi; Michele Muggeo; Enzo Bonora
The study purpose was to determine the following in a large sample of hospitalized patients: (1) the prevalence of hyperuricemia, (2) the association of hyperuricemia with other metabolic disorders, and (3) the factors independently predicting hyperuricemia. Five hundred adult patients (250 men and 250 women) were randomly selected from those admitted as inpatients over a period of 5 months. In all patients, body mass index (BMI), blood pressure, and serum glucose, lipid, creatinine, urea nitrogen, and urate concentrations were measured. The presence of diseases or use of medications known to affect serum urate levels were recorded. The mean level of serum urate was 5.6 mg/dL in the whole sample, 6.0 mg/dL in men and 5.3 mg/dL in women (P = .003, men v women). The prevalence of hyperuricemia was 27.6% (28.8% and 26.4% in men v women, P = nonsignificant). A definite or probable secondary hyperuricemia was found in 87.7% of the subjects. Hyperuricemia was rarely isolated (21%), whereas it was frequently associated with hypertension (60.1%), hyperlipidemia (31.2%), diabetes (28.3%), and obesity (21.7%). In 26.8% of the subjects, hyperuricemia was associated with two metabolic disorders, in 13.8% with three, and in 2.9% with four. Multiple metabolic disorders (three to four) were found in 16.7% of subjects with hyperuricemia. Serum urate levels progressively increased across a range of subjects from those without diabetes, hyperlipidemia, hypertension, or obesity to those with one, two, or a greater number of associated metabolic abnormalities. Multiple stepwise regression analysis showed that 43% of serum urate variability was explained by urea nitrogen levels, triglyceride levels, diuretic therapy, the inverse of creatinine (as an index linearly related to creatinine clearance), and BMI. These results indicate that in hospitalized subjects, hyperuricemia is (1) frequent, (2) a secondary phenomenon in most cases, and (3) frequently associated with other metabolic disorders. The major predictors of high serum urate levels are BMI, triglycerides, parameters of renal function, and use of diuretics. These variables explain a large proportion of serum urate variability.
Diabetic Medicine | 2002
Enzo Bonora; Giovanni Targher; Maria Alberiche; Gianni Formentini; Francesco Calcaterra; Simonetta Lombardi; F. Marini; M. Poli; Luciano Zenari; A. Raffaelli; S. Perbellini; Marina B. Zenere; Francesca Saggiani; Riccardo C. Bonadonna; Michele Muggeo
Aims To identify the independent predictors of insulin sensitivity in Type 2 diabetes, and to establish whether isolated Type 2 diabetes (i.e. diabetes without overweight, dyslipidaemia and hypertension) is a condition of insulin resistance.
European Journal of Clinical Investigation | 2003
Enzo Bonora; Giovanni Targher; Marina B. Zenere; Francesca Saggiani; Vittorio Cacciatori; Flavia Tosi; D. Travia; M G Zenti; P. Branzi; Lorenza Santi; Michele Muggeo
The associations between fasting plasma insulin concentration and risk factors for cardiovascular diseases were examined in 979 18‐year‐old men participating in the Verona Young Men Atherosclerosis Risk Factors Study, a cross‐sectional population‐based study. Body mass index (BMI), waist‐to‐hip ratio (WHR), plasma triglycerides and uric acid concentrations, and blood pressure values significantly increased, and the high‐density lipoprotein (HDL)–total cholesterol ratio decreased, across quartiles of fasting insulin. Total and low‐density lipoprotein cholesterol concentrations did not change significantly with the increase in fasting insulin levels. After adjustment for BMI, WHR, smoking, alcohol intake and physical activity, only plasma triglycerides significantly increased across insulin quartiles (F =7.1; P <0.001). However, systolic blood pressure and uric acid were close to statistical significance (P =0.06–0.07). Multiple linear regression analysis confirmed that plasma insulin was independently correlated with plasma triglycerides and, to a lesser extent, with blood pressure and uric acid concentration. This analysis pointed out that BMI was a stronger independent predictor of all cardiovascular disease risk factors than fasting insulin. When subjects were categorized according to the number of metabolic and haemodynamic disorders occurring within the same individual, subjects with multiple disorders (i.e. three or four) had higher plasma insulin levels than those with none or few disorders, even after adjusting for BMI, WHR and behavioural variables (F =4.0; P <0.01). These results indicate that hyperinsulinaemia is already associated with a cluster of cardiovascular disease risk factors in young adulthood, the strongest independent association being with plasma triglycerides.
Journal of Internal Medicine | 2007
Enzo Bonora; Giovanni Targher; Marina B. Zenere; Francesca Saggiani; Maria Alberiche; P. Branzi; Michele Muggeo
Abstract. Bonora E, Targher G, Zenere MB, Saggiani F, Alberiche MP, Branzi P, Muggeo M. (University of Verona Medical School, Verona, Italy). Obesity worsens cardiovascular risk profiles independently of hyperinsulinaemia.
Diabetes Care | 2000
Enzo Bonora; Giovanni Targher; Maria Alberiche; Riccardo C. Bonadonna; Francesca Saggiani; Marina B. Zenere; Tiziano Monauni; Michele Muggeo
Diabetes Care | 2002
Enzo Bonora; Gianni Formentini; Francesco Calcaterra; Simonetta Lombardi; Franco Marini; Luciano Zenari; Francesca Saggiani; Maurizio Poli; Sandro Perbellini; Andrea Raffaelli; Vittorio Cacciatori; Lorenza Santi; Giovanni Targher; Riccardo C. Bonadonna; Michele Muggeo
Diabetes Care | 1999
Guido Arcaro; Beatrice Marina Zenere; Francesca Saggiani; M G Zenti; Tiziano Monauni; Alessandro Lechi; Michele Muggeo; Riccardo C. Bonadonna
The Journal of Clinical Endocrinology and Metabolism | 1999
Enzo Bonora; Giovanni Targher; Maria Alberiche; Riccardo C. Bonadonna; Francesca Saggiani; Marina B. Zenere; Stefano Uleri; Michele Muggeo